The World s First Published Expert Consensus on ARNI Treatment For Hypertension
Chinese Expert Recommendation On The Clinical Application Of Sacubitril/Valsartan in Patients With Hypertension
Perspectives
A
The Chinese Expert Consensus Recommendations on the Clinical Application of Sacubitril/valsartan in Patients With Hypertension document was recently published in the
Chinese Journal of Hypertension (2021; 29(2): 108-114). The recommendations were jointly compiled by the hypertension branch of the China International Exchange and Promotive Association for Medical and Health Care, the cardiovascular branch of the Chinese Medical Doctor Association, and the Chinese Hypertension League. Because it is the first expert consensus on the treatment of hypertension using angiotensin receptor neprilysin inhibitor (ARNI), it is expected to serve as an important reference for developing standardized clinical application protocols for this drug.